Turn ASCO data into business-critical insights. 30 high-prescribing hem/oncs analyze 8-10 Chronic Lymphocytic Leukemia (CLL) abstracts to help you prepare for what’s next. Take the guesswork out of understanding changes in prescribing behavior for acalabrutinib, ibrutinib, and venetoclax among ohters. Get your 60+ slide report.

Chronic Lymphocytic Leukemia Report ASCO 2021

American Society of Clinical Oncology

Virtual Meeting
Jun 4 to Jun 8

Share: